Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Sickle Cell Market Report 2017 - Industry Analysis & Outlook 2020-2030 - Research and Markets

Research and Markets
Posted on: 15 Aug 17

The "Global Sickle Cell Market - Industry Analysis & Outlook (2020-2030)" report has been added to Research and Markets' offering.

Global Sickle Cell Market: Industry Analysis & Outlook (2017-2021) provides an extensive research and detailed analysis of the present market along with future outlook.

The report discusses the major growth drivers and challenges of the market, covering the U.S. and Europe along with the global market. The report profiles key players of the market including Novartis, Bristol-Myers Squibb, Shire Plc, Bluebird Bio and Global Blood Therapeutics Inc.

The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.

The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.

Key Topics Covered:

1. Overview

1.1 Sickle Cell

1.2 Types of Sickle Cell

1.3 Symptoms & Diagnosis

1.4 Treatment

2. Global Market

2.1 Global Sickle Cell Drug Market Forecast by Value

2.2 Sickle Cell Drug Market by Region

3. Regional Market

3.1 The U.S.

3.1.1 The U.S. Sickle Cell Drug Market Forecast by Value

3.1.2 The U.S. Sickle Cell Patient Volume Forecast

3.1.3 The U.S. Sickle Cell Treated Patient Volume Forecast

3.1.4 The U.S. Sickle Cell Market Forecast by Treatment Cost

3.2 Europe

3.2.1 Europe Sickle Cell Drug Market Forecast by Value

3.2.2 Europe Sickle Cell Patient Volume Forecast

3.2.3 Europe Sickle Cell Treated Patient Volume Forecast

3.2.4 Europe Sickle Cell Market Forecast by Treatment Cost

4. Market Dynamics

4.1 Growth Drivers

4.1.1 Rising American-African Population

4.1.2 Rising Economic Growth

4.1.3 Increasing Healthcare Expenditure

4.1.4 Increasing Prevalence of Sickle Cell

4.2 Key Trends

4.2.1 Progressing Drug Pipeline

4.2.2 Rising Research Grants

4.3 Challenges

4.3.1 Regulatory Challenges

4.3.2 Associated Risks

4.3.3 Slow Adoption of Treatment

5. Competition

5.1 Global Market

5.1.1 Revenue Comparison of Key Players

5.1.2 Market Cap Comparison of Key Players (2016)

6. Company Profiles

  • Bluebird Bio
  • Bristol-Myers Squibb
  • Global Blood Therapeutics Inc.
  • Novartis
  • Shire Plc.

For more information about this report visit

View source version on

Business Wire

Last updated on: 15/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.